Skip to content
All Sections
Subscribe Now
60°F
Monday, July 29th 2024
Today's E-Edition
Home Page
Close Menu
Business
Technology
Commercial Real Estate
Housing
Marketplace
The Mercury News
SUBSCRIBE NOW
Close Menu
Morning Report in your inbox!
Sign Up
Subscribe
Account Settings
Contact Us
Log Out
Spoof a user
Morning Report in your inbox!
Sign Up
Subscribe
Search
Silicon Valley
60°F
Monday, July 29th 2024
Today's E-Edition
Business
Technology
Commercial Real Estate
Housing
Marketplace
The Mercury News
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vaneck Pharmaceutical ETF
(NQ:
PPH
)
93.28
UNCHANGED
Streaming Delayed Price
Updated: 4:15 PM EDT, Jul 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
93.28
Bid (Size)
92.11 (1)
Ask (Size)
93.96 (1)
Prev. Close
93.28
Today's Range
93.28 - 93.28
52wk Range
74.05 - 93.85
Shares Outstanding
N/A
Dividend Yield
1.67%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Ozempic Maker Novo Nordisk Closes In On Lego As Denmark's Most Valuable Brand: Report
June 12, 2024
Novo Nordisk is challenging Lego A/S for the title of Denmark's most valuable brand, with its brand value surging 59% to $5.1 billion. This growth is fueled by the global popularity of its weight-loss...
Via
Benzinga
Just Say No to Drugs: 3 Pharma Stocks to Avoid
May 08, 2024
Discover which pharma stocks to avoid in 2023 as we delve into market trends, financial struggles, and the impact on investor portfolios.
Via
InvestorPlace
Performance
YTD
+12.89%
+12.89%
1 Month
+1.97%
+1.97%
3 Month
+7.06%
+7.06%
6 Month
+9.33%
+9.33%
1 Year
+15.99%
+15.99%
More News
Read More
A Look At Pharma ETFs Post Q1 Earnings
May 07, 2024
Via
Talk Markets
Topics
ETFs
ETFs To Buy As Eli Lilly Beats Q1 Earnings, Lifts Outlook
May 01, 2024
Via
Talk Markets
Topics
ETFs
3 Weight-Loss ETFs to Profit From the Obesity Drug Boom
April 17, 2024
Via
InvestorPlace
Topics
ETFs
Novo Nordisk's Game-Changer: FDA Approves Weight Loss Sensation Wegovy For Heart Health, Potential Insurance Coverage
March 08, 2024
Via
Benzinga
Exposures
Product Safety
The Top 3 ETFs to Buy in March 2024
March 07, 2024
Via
InvestorPlace
Topics
ETFs
11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher Yields
February 28, 2024
Via
Benzinga
A Look At Pharma ETFs After Q4 Earnings
February 12, 2024
Via
Talk Markets
Topics
ETFs
5 ETF Zones Scaling New Highs At The Start Of 2024
January 08, 2024
Via
Talk Markets
Topics
ETFs
Government-granted Patent Monopolies Are Not The Free Market
December 29, 2023
Via
Talk Markets
Topics
Intellectual Property
Exposures
Intellectual Property
Preparing For The Next Short-Term Rally Higher
August 12, 2023
Via
Talk Markets
Pharma ETFs in Focus Post Q2 Earnings
August 11, 2023
Via
Talk Markets
Topics
ETFs
The 3 Most Undervalued Pharma Stocks to Buy Now: July 2023
July 21, 2023
Via
InvestorPlace
Pharma ETFs Gain Post Q1 Earnings
May 09, 2023
Via
Talk Markets
A Look At Pharma ETFs Post Q4 Earnings
February 08, 2023
Via
Talk Markets
5 Sector ETFs That Beat The Market In December
December 27, 2022
Via
Talk Markets
Pharma ETFs In Focus Post Q3 Earnings
November 09, 2022
Via
Talk Markets
Wave of Solid Q3 Earnings Push Pharma ETFs Higher
November 09, 2021
Via
Talk Markets
Pharma ETFs in Focus Post Q1 Earnings
May 12, 2021
Via
Talk Markets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Close
